Education
About Us
Working with TipRanks
Follow Us
Cidara Therapeutics (CDTX)
NASDAQ:CDTX
Earnings Data
Report Date
Mar 11, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-1.58Last Year’s EPS
-5.37Same Quarter Last Year
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted significant progress in the development and funding of CD388, along with strong financial positioning. However, there are challenges related to manufacturing scale-up and uncertainties in flu vaccination rates and study enrollment timing.Company Guidance
Accelerated Phase III Development of CD388
CD388 has advanced into Phase III development six months earlier than planned, with expanded patient population and FDA breakthrough therapy designation.
BARDA Funding Secured
Cidara received up to $339 million from BARDA to support CD388 manufacturing and clinical development, with $58 million for initial activities.
Strong Financial Position
Cidara has approximately $476 million in cash, fully funding the Phase III program through completion.
Positive Phase IIb Results
CD388's Phase IIb study met its primary endpoint with 76.1% protective efficacy, supporting Phase III dose selection.
CDTX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CDTX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | $98.64 | $104.39 | +5.83% |
Aug 07, 2025 | $61.73 | $62.00 | +0.44% |
May 08, 2025 | $19.15 | $18.63 | -2.72% |
Mar 06, 2025 | $23.61 | $23.66 | +0.21% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cidara Therapeutics (CDTX) report earnings?
Cidara Therapeutics (CDTX) is schdueled to report earning on Mar 11, 2026, TBA (Confirmed).
What is Cidara Therapeutics (CDTX) earnings time?
Cidara Therapeutics (CDTX) earnings time is at Mar 11, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CDTX EPS forecast?
CDTX EPS forecast for the fiscal quarter 2025 (Q4) is -1.58.